Editor - Mario Alfredo Parra Rodriguez | Heriot-Watt University | 13467
ISSN: 2376-0311

JBR Journal of Clinical Diagnosis and Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mario Alfredo Parra Rodriguez

Mario Alfredo Parra Rodriguez
Mario Alfredo Parra Rodriguez
School of Social Scinces, Psychology
Heriot-Watt University
United Kingdom


I graduated as a Medical Doctor in 1993 and as a Clinical Neurophysiologist in 1997. My initial research work focused on electrophysiological, psychophysiological, social and cognitive aspects of dementia. From 1997 until 2005 I worked at the Cuban Neuroscience Centre and at different University Hospitals in Cuba and in Colombia.In 2005 I was awarded a scholarship by the European Program ALBAN to undertake a PhD at the University of Edinburgh. The aim was to develop tools for the early detection of Alzheimer’s disease (AD). After completing my PhD in 2009, the Neuroscience Program of the San Paolo Foundation awarded me a 2-year fellowship to further my studies developing cognitive tools for the early detection of AD. In 2012 Alzheimer’s Society awarded me a 3-year fellowship to help me turn these novel methodologies into clinical tools. I currently work collaboratively with a network of groups around the world.

Research Interest

Cognitive mechanisms underlying normal and abnormal ageing. Cognitive and behavioural changes in neurodegenerative diseases, with emphasis on Alzheimer’s Disease. The investigation of functional brain changes (fMRI and ERPs) in the course of dementing illnesses and other brain disorders. Development of cognitive tests for the early detection of dementia with emphasis on Alzheimer’s disease. Development of technology based intervention procedures to enahnce functions of everyday life in older people who are experiencing cognitive decline.